Asano Y. The Pathogenesis of Systemic Sclerosis: An Understanding Based on a Common Pathologic Cascade across Multiple Organs and Additional Organ-Specific Pathologies. J Clin Med. 2020 Aug 19;9(9):2687. https://doi.org/10.3390/jcm9092687.
Lepri G, Orlandi M, Di Battista M, De Mattia G, Da Rio M, Codullo V, et al. Systemic sclerosis: one year in review 2022. Clin Exp Rheumatol. 2022;40(10):1911–20. https://doi.org/10.55563/clinexprheumatol/3401fl.
Bakhos CT, Petrov RV, Parkman HP, Malik Z, Abbas AE. Role and safety of fundoplication in esophageal disease and dysmotility syndromes. J Thorac Dis. 2019;11(Suppl 12):1610–S7. https://doi.org/10.21037/jtd.2019.06.62.
Martin-Lopez M, Carreira PE. The impact of progressive pulmonary fibrosis in systemic sclerosis-associated interstitial lung disease. J Clin Med. 2023;12:6680.
Article CAS PubMed PubMed Central Google Scholar
Das A, Kumar A, Arrossi AV, Ghosh S, Highland KB. Scleroderma-related interstitial lung disease: principles of management. Expert Rev Respir Med. 2019;13(4):357–67.
Article CAS PubMed Google Scholar
Hoffmann-Vold AM, Maher TM, Philpot EE, Ashrafzadeh A, Barake R, Barsotti S, et al. The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statement. Lancet Rheumatol. 2020;2:e71–83.
Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an update) and progress pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205:e18–47.
Article PubMed PubMed Central Google Scholar
Vettori S, Barra G, Russo B, Borgia A, Pasquale G, Pellecchia L, et al. T‑Cell Proapoptotic and Antifibrotic Activity Against Autologous Skin Fibroblasts in vitro Is Associated With IL-17A Axis Upregulation in Systemic Sclerosis. Front Immunol. 2020;27(11):220. https://doi.org/10.3389/fimmu.2020.00220.
Mattoo H, Pillai S. Idiopathic pulmonary fibrosis and systemic sclerosis: pathogenic mechanisms and therapeutic interventions. Cell Mol Life Sci. 2021;78:5527–42.
Article CAS PubMed PubMed Central Google Scholar
Eberlein M, Mathai SC. Lung transplantation in scleroderma. Time for the pendulum to swing? Ann Am Thorac Soc. 2016;13(6):767–9.
Distler O, Gahlemann M, Maher TM. Nintedanib for systemic sclerosis-associated interstitial lung disease. N Eng J Med. 2019;380;26:2518–28.
Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol. 2022 Jan 1;117(1):27–56. https://doi.org/10.14309/ajg.0000000000001538.
Savarino E, Bazzica M, Zentilin P, Pohl D, Parodi A, et al. Gastroesophageal reflux and pulmonary fibrosis in scleroderma. Am J Respir Crit Care Med. 2009;179:408–13.
Aiolfi A, Nosotti M, Matsushima K, Perali C, Ogliari C, Del Papa N, et al. Surgical treatment of recalcitrant gastroesophageal reflux disease in patients with systemic sclerosis: a systematic review. Langenbecks Arch Surg. 2021;406(5):1353–61. https://doi.org/10.1007/s00423-021-02118-8.
Article PubMed PubMed Central Google Scholar
Orringer MB, Orringer JS, Dabich L, Zarafonetis CJ. Combined Collis gastroplasty—fundoplication operations for scleroderma reflux esophagitis. Surgery. 1981;90(4):624–30. PMID: 7281001.
Mansour KA, Malone CE. Surgery for scleroderma of the esophagus: a 12-year experience. Ann Thorac Surg. 1988 Nov;46(5):513–4. https://doi.org/10.1016/s0003-4975(10)64687-5.
Poirier NC, Taillefer R, Topart P, Duranceau A. Antireflux operations in patients with scleroderma. Ann Thorac Surg. 1994 Jul;58(1):66–72; discussion 72–3. https://doi.org/10.1016/0003-4975(94)91073-1.
Kent MS, Luketich JD, Irshad K, Awais O, Alvelo-Rivera M, Churilla P, et al., Comparison of surgical approaches to recalcitrant gastroesophageal reflux disease in the patient with scleroderma. Ann Thorac Surg. 2007 Nov;84(5):1710–5; discussion 1715–6. https://doi.org/10.1016/j.athoracsur.2007.06.025.
Yekeler E, Gürsan N. Esophagectomy in scleroderma: report of a case. Case Rep Gastroenterol. 2008;2(3):499–504. https://doi.org/10.1159/000161565.
Article PubMed PubMed Central Google Scholar
Andrade A, Folstein MK, Davis BR. Case report of robotic dor fundoplication for scleroderma esophagus with aperistalsis on manometry. Int J Surg Case Rep. 2017;37:69–71. https://doi.org/10.1016/j.ijscr.2017.06.020.
Article PubMed PubMed Central Google Scholar
Yan J, Strong AT, Sharma G, Gabbard S, Thota P, Rodriguez J, et al. Surgical management of gastroesophageal reflux disease in patients with systemic sclerosis. Surg Endosc. 2018;32(9):3855–60. https://doi.org/10.1007/s00464-018-6115-2.
Rivera PCJ, Kadamani Abiyomaa A, González-Orozco A, Ocampo MA, Caicedo I, Mosquera MS. Total gastrectomy in systemic scleroderma when anti-reflux surgery is not viable: A case report. Int J Surg Case Rep. 2019;62:103–7. https://doi.org/10.1016/j.ijscr.2019.08.022.
Loganathan P, Gajendran M, Davis B, McCallum R. Efficacy and Safety of Robotic Dor Fundoplication on Severe Gastroesophageal Reflux Disease in Patients With Scleroderma. J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211051211. https://doi.org/10.1177/23247096211051211.
Hii A, Liu DS, Kholmurodova F, Irvine T, Bright T, Watson DI, et al. Partial Fundoplication is Effective Treatment for Female Patients with Gastroesophageal Reflux and Scleroderma: A Multicenter Comparative Cohort Study. World J Surg. 2022;46(1):147–53. https://doi.org/10.1007/s00268-021-06326-7.
Goldberg MB, Abbas AE, Smith MS, Parkman HP, Schey R, Dempsey DT. Minimally Invasive Fundoplication Is Safe and Effective in Patients With Severe Esophageal Hypomotility. Innovations (Phila). 2016 Nov/Dec;11(6):396–399. https://doi.org/10.1097/IMI.0000000000000318.
Watson DI, Jamieson GG, Bessell JR, Devitt PG. Laparoscopic fundoplication in patients with an aperistaltic esophagus and gastroesophageal reflux. Dis Esophagus. 2006;19(2):94–8. https://doi.org/10.1111/j.1442-2050.2006.00547.x.
Article CAS PubMed Google Scholar
Gyawali C, Yadlapati R, Fass R, Katzka D, Pandolfino J, Savarino E, et al. Updates to the modern diagnosis of GERD: Lyon consensus 2.0. Gut. 2024;73:361–71.
Bona D, Aiolfi A, Asti E, Bonavina L. Laparoscopic Toupet fundoplication for gastroesophageal reflux disease and hiatus hernia: proposal for standardization using the “critical view” concept. Updates Surg. 2020;72(2):555–8. https://doi.org/10.1007/s13304-020-00732-7.
Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract. 2004;10(2):307–12. https://doi.org/10.1111/j..2002.384.doc.x.
Teare MD, Dimairo M, Shephard N, Hayman A, Whitehead A, Walters SJ. Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study. Trials. 2014;3(15):264. https://doi.org/10.1186/1745-6215-15-264.
Tamburini N, Andolfi C, Fisichella PM. A narrative review of minimally invasive fundoplication for gastroesophageal reflux disease and interstitial lung disease. Ann Esophagus. 2022;5:42.
Kreuter M, Bonella F, Blank N, Riemekasten G, Muller-Ladner U, Henes J, et al. Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German network for systemic sclerosis. Baillieres Clin Rheumatol. 2023;62:3067–74.
Raghu G, Montesi SB, Silver RM, Hossain T, Macrea M, Herman D, et al. Treatment of systemic sclerosis-associated interstitial lung disease: evidence-based recommendations. Am J Respir Crit Care Med. 2024;209(2):137–52.
Article PubMed PubMed Central Google Scholar
Rahaghi FF, Hsu VM, Kaner RJ, Mayes MD, Rosas IO, Saggar R, et al. Expert consensus on the management of systemic sclerosis-associated interstitial lung disease. Respir Res. 2023;24:6.
Article PubMed PubMed Central Google Scholar
Fisichella PM Davis CS, Kovacs EJ. A review of the role of GERD-induced aspiration after lung transplantation. Surg Endosc 2012 May ; 26(5): 1201–1204. https://doi.org/10.1007/s00464-011-2037-y
Cottin V, Brown KK. Interstitial lung disease associated with systemic sclerosis (SSc.ILD). Respir Res. 2019; 20–13.
Robertson AGN, Shenfine J, Ward C, Pearson JP, Dark JH, Corris PA, et al. A call for standardization of antireflux surgery in the lung transplantation population. Transplantation. 2009;87(8):112–4.
Hoppo T, Jarido V, Pennathur A, Morrell M, Crespo M, Shigemura N, et al. Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation. Arch Surg. 2011;146(9):1041–7.
Biswas Roy S, Elnahas S, Serrone R, Haworth C, Olson MT, Kang P, et al. Early fundoplication is associated with slower decline in lung function after lung transplantation in patients with gastroesophageal reflux disease. J Thorac Cardiovasc Surg. 2018;155(6):2762–71.
Razia D, Mittal SK, Fournier S, Walia R, Smith MA, Bremner RM, et al. Antireflux surgery versus medical management of gastro-esophageal reflux after lung transplantation. Eur J Cardio-thor Surg. 2023;63(3).
Davidson JR, Franklin D, Kumar S, Mohammadi B, Dawas K, Eaton S, et al. Fundoplication to preserve allograft function after lung transplant: systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2020;160:858–66.
Linden PA, Gilbert RJ, Yeap BY, Boyle K, Deykin A, Jaklitsch MT, et al. Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. J Thorac Cardiovasc Surg. 2006;131:438–46.
Bonavina L. Toupet versus Nissen fundoplication for gastroesophageal reflux disease: are the outcomes different? Dig Med Res. 2023;6:4. https://doi.org/10.21037/dmr-22-65
留言 (0)